The company will deliver an oral presentation on ADRX-0405, its clinical-stage STEAP1 ADC, and a poster presentation on ADRX-0134, its preclinical Na ...
One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...
FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced two plixorafenib abstracts have been ...
Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001Erasca will also present ...
Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile VANCOUVER, British Columbia, March 25, 2025 (GLOBE ...
A Nintendo Direct about the Switch 2 is coming next week, but Nintendo might have a Switch 1 presentation on tap for this ...
The Shining is a cult classic horror movie beloved by film fans, and its original poster is widely considered one of the most iconic designs in cinema history – you only have to look at Jack Nicholson ...
We asked a few yard sale veterans to share their best hard-earned wisdom for hosting a yard sale in these modern times. While ...
Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for ...
The 2025 Stuart Sutherland Best Oral Presentation and Best Poster winners, as voted on by attendees, were announced during a reception in the exhibit hall on February 26. Participants from 32 ...
The Edgewise presentation and posters will be available on the Edgewise website when they are presented. Sevasemten is an orally administered first-in-class fast skeletal myosin inhibitor designed ...
Courtesy of Cal Poly Pomona Jordan Johnson, a criminology student, was part of a research group last year that won the award for the best poster presentation. Johnson presented two topics at the 2024 ...